Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Efficacy of leprosy vaccines across the globe: A systematic review & meta-analysis of randomized controlled trials.

Dasgupta S, Mukherjee S, Bagchi C, et al. The Indian journal of medical research. 2024; 160 (3&4) : 293-302.
Download PDF
Publication

Leprosy and its impact on the quality of life of people with physical disabilities: a scoping review

Araujo DMD, Silva ECDSE, Gomes HVDS, et al. FapUNIFESP (SciELO). Revista Brasileira de Enfermagem. 2024; 77 (suppl 3) : 1-10.
Download PDF
Publication

Disabilities in leprosy patients ascertained in a total population survey in Karonga District, Northern Malawi

Ponnighaus IM, Boerrigter G, Fine P, et al. Lepr. rev. 1990;
Download PDF
Publication

The epidemiology of leprosy in Karonga District, northern Malawi 1973–2023: An analysis of leprosy’s distribution, risk factors, control and decline in rural Africa

LEP - KPS Team . Lepra. Leprosy Review. 2024; 95 (1) : 7-84.
Download PDF
Publication

The leprosy endgame in Malawi: From leprosy control project to national public health resource

Crampin AC, Nyirenda M, Fine PEM. Lepra. Leprosy Review. 2024; 95 (1) : 2-6.
Download PDF
Practical material

Community Mental Health Good Practice Guide: Community Mental Health Forums

CBM . 2021;
Access resource
Publication

How much has been achieved to prevent and control leprosy in Malawi since 2012?

Muula A. Malawi medical journal : the journal of Medical Association of Malawi. 2022; 34 (3) : 151.
Download PDF
Publication

BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.

Glynn J, Fielding K, Mzembe T, et al. The Lancet. Global health. 2021; 9 (10) : e1451-e1459.
Download PDF
Publication

The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi.

Glynn J, Dube A, Fielding K, et al. The Lancet. Infectious diseases. 2021;
Download PDF
Publication

Knowledge About Leprosy Among Health Care Workers In Balaka District, Southern Malawi

Mponda K, Anafi G, Laja ET, et al. Research Square. 2020;
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Malawi

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD